期刊文献+

牛分支杆菌ag85b基因的克隆及表达 被引量:1

Cloning and Prokaryotic Expression of ag85b Gene of Mycobacterium Bovis
下载PDF
导出
摘要 以牛分支杆菌C68001株基因组DNA为模板,克隆免疫优势抗原基因ag85b,构建重组表达质粒pET-28a-ag85b,转化入大肠埃希菌BL21(DE3),IPTG诱导表达重组蛋白,对表达产物进行SDS-PAGE分析和Western blot鉴定。结果表明,构建了ag85b基因的重组基因工程菌株,IPTG诱导表达的重组蛋白分子质量约为33ku,目的蛋白能被His单克隆抗体识别,表达产物主要以包涵体形式存在。 To clone and express the geneen coding Mycobacterium tuberculosis antigen Ag85B, a pair of spe- cific primers were designed, the Ag85B gene was amplified from the genomic DNA by PCR, and cloned in- to vector PET28a (+) to construct the recombinant plasmid. The recombinant plasmid was transformed into the expression vector Escherichia coli BL21 (DE3), and induced with IPTG; the presence of the recombinant protein in the expression vector was analysed by SDS-PAGE and Western blot. Results showed that the ag85b gene was successfully expressed with expected 33 ku in molecular weight. It can be specifically recognized by His McAb.
出处 《动物医学进展》 CSCD 北大核心 2013年第5期44-47,共4页 Progress In Veterinary Medicine
基金 国家自然科学基金项目(31160515)
关键词 牛分支杆菌 Ag85B抗原 原核表达 Mycobacterium bovis antigen Ag85B protokaryon expression
  • 相关文献

参考文献3

二级参考文献16

  • 1姜秀云,王春凤,王春芳,何昭阳.牛分枝杆菌Ag85A基因的克隆及序列分析[J].中国兽医科技,2004,34(9):21-24. 被引量:1
  • 2江山,朱道银,骆旭东,蒋英,陈全.结核分枝杆菌DNA疫苗对小鼠结核病免疫治疗作用的实验研究[J].中华结核和呼吸杂志,2005,28(5):305-309. 被引量:18
  • 3Stanford L.Peng.The T-box Transcription Factor T-bet in Immunity and Autoimmunity[J].Cellular & Molecular Immunology,2006,3(2):87-95. 被引量:11
  • 4刘忠华,万康林,陈创夫.结核分枝杆菌主要分泌蛋白的研究进展[J].中国人兽共患病学报,2007,23(7):722-724. 被引量:7
  • 5Dye C D, Scheele S M S, Dolin P D,et al. Global burden of tuberculosis estimated incidence, prevalence, and mortality by country [J].Journal of the American Medical Association,1999,282(7):677-686.
  • 6Tollefsen S, Vordermeier M, Ulsen I, et al. DNA injection in combination with electroporation: a novel method for vaccination of farmed ruminants [J].Scandinavian Journal of Immunology,2003,57(3):229-238.
  • 7Colditz G A, Brewer T F, Berkey C S, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta analysis of the published literature [J].Journal of the American Medical Association,1994, 271(9):698-702.
  • 8Fine P E M. Variation in protection by BCG: implications of and for heterologous immunity [J].Lancet,1995,346 (8986):1339-1345.
  • 9Andersen P, Askgaard D, Gottschau A, et al. Identification of immunodominant antigens during infection with Mycobacterium tuberculosis [J].Scandinavian Journal of Immunology,1992,36(6):823-831.
  • 10Andersen P. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins [J].Infection and Immunity,1994,62(6):2536-2544.

共引文献11

同被引文献20

  • 1BRENNAN M J.The tuberculosis vaccine challenge[J]. Tuber- culosis, 2005,85 ( 1-2 ) : 7-12.
  • 2ANDERSEN P.Tuberculosis vaccines-an update[J]. Natuer Re- views Microbiology, 2007,5 (7) : 484-487.
  • 3DYE C,SCHEELE S,DOLIN P,et al.Global burden of tubercu- losis[J]. JAMA:the Journal of the American Medical Assoeia- tion, 1999,282 : 677-686.
  • 4LIBERATO I R, ALBUQUERQUE MDE F, CAMPELO A R, et al. Characteristics of pulmonary tuberculosis in HIV seropos- itive and seroncgative patients in a Northeastern region of Brazil[J]. Rev Snc Bras Med Trop,2004,37(1):46-50.
  • 5GAO H F, YUE Y, HU L K, et al. A novel DNA containing multiple TB-spitopes casted in a natural structure (ECANS) confers protective immunity against pulmonary myeobaeterial challenge[J]. Vaccine,2009,27(39) :5313-5319.
  • 6VON KALLE C.Gene therapy: a tragic setback[J]. Nature, 2002,420(6912) : 116-118.
  • 7RG C. Transfer of genes to humans: early lessons and obsta- cles to success[J]. Science , 1995,270(5235) :404-410.
  • 8ZHANG X J, GODBEY W T. Viral vectors for gene delivery in tissue engineering [J]. Adv Drug Deliv Rev,2006,58(4): 515-534.
  • 9MARGARET A C, LAURA M E, SIOBHAN M,et al. Pro- ection against Bordetella pertussis infection following parenteral r oral immunization with antigens entrapped in biodegradable aricles: effect of formulation and route of immunization on nduction of Thl and Th2 cells[J].Vaccine,2001,19(15-16)) : 1940-1950.
  • 10SEKI J, SONOKE S, SAHEKI A, et al. A nanometer lipid emulsion, lipid nano-sphere(LNS), as a parenteral drug car- rier for passive drug targeting[J]. ]nt J ]?harm, 2004,273(1- 2) :75-83.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部